Lanzamiento Enero 2027

Ensayo controlado aleatorizado1997

Absorption and subjective effects of caffeine from coffee, cola and capsules

Liguori A, Hughes JR, Grass JA

Pharmacology, biochemistry, and behavior · 85 citas

Cómo se estudió

Diseño
Ensayo controlado aleatorizado (indexado por PubMed)
Estudiado en
Personas
Resultado principal
Marcadores de salud y funcionamiento

Quién lo pagó

Financiación
Financiación independiente
Gobierno
National Institute on Aging
Gobierno
National Institute on Drug Abuse
Gobierno
NIDA NIH HHS
Subvenciones
National Institute on Drug Abuse (DA-04843); National Institute on Drug Abuse (DA00109)

Según 3 financiadores declarados.

Publicación

Publicado
1997-11-01 · Pharmacol Biochem Behav · vol. 58 · número 3 · págs. 721–726
Editorial
Elsevier BV
Citado
168 citas · más que el 68% de estudios similares · 0.5× el promedio de su campo
Referencias
29 trabajos
Acceso
De pago
Áreas de investigación
Coffee research and impacts · Sleep and Work-Related Fatigue · Neurotransmitter Receptor Influence on Behavior
Palabras clave
caffeine, coffee, cola, subjective effects, vehicle effects, caffeine dose
MeSH
saliva, humans, substance withdrawal syndrome, caffeine, central nervous system stimulants, capsules, area under curve, double-blind method, behavior, affect, dose-response relationship, drug, carbonated beverages, coffee, adult, female, male

1 autor

  • Anthony Liguori🇺🇸 · autor de correspondenciaUniversity of Vermont

Resumen

El texto original del estudio, en el idioma en que se publicó.

Coffee is often perceived as producing greater pharmacological effects than cola. The present study compared the magnitude and rapidity of peak caffeine levels and subjective effects between coffee and cola. Thirteen users of both coffee and cola (mean daily caffeine consumption = 456 mg) ingested 400 mg caffeine via 12 oz unsweetened coffee, 24 oz sugar-free cola or 2 capsules in a random, double-blind, placebo-controlled, within-subjects design. Subjects provided a saliva sample and completed subjective effect scales 15 min before and 30, 60, 90, 120, 180 and 240 min after ingestion. Mean peak saliva caffeine levels did not differ between coffee (9.7 +/- 1.2 micrograms/ml) and cola (9.8 +/- 0.9 micrograms/ml) and appeared to be greater with these beverages than with the capsule (7.8 +/- 0.6 micrograms/ml; p = NS). Saliva caffeine levels peaked at similar times for coffee (42 +/- 5 min) and cola (39 +/- 5 min) but later for capsule (67 +/- 7 min; p = 0.004). There was no main effect of vehicle or interaction of vehicle and drug on magnitude of peak effect or time to peak increase on self-report scales. In summary, peak caffeine absorption, time to peak absorption, and subjective effects do not appear to be influenced by cola vs. coffee vehicle. Perceived differences in the effects of coffee vs. cola may be due to differences in dose, time of day, added sweetener, environmental setting or contingencies.

Resumen vía Europe PMC. Los derechos de autor siguen siendo de los autores o la editorial.

Confianza de la comunidad

Cargando…

¿Cuánto confías en los hallazgos de este estudio?

0 · nada10 · totalmente

Comentarios

¿Algo está mal aquí?

Señala este estudio si su información, etiquetas o financiación parecen incorrectas. Un editor revisa cada señalamiento.

Información educativa sobre investigación publicada. No es consejo médico ni una recomendación para empezar o dejar nada.